Regulatory

The U.S. Food and Drug Administration (FDA) has responded to a citizen petition from the Natural Products Association (NPA) and the Alliance for Natural Health (ANH) requesting that FDA reevaluate its position on nicotinamide mononucleotide.

The U.S. Hemp Roundtable is raising the alarm about an amendment to Assembly Bill 420 (AB420) filed by the California Department of Public Health.

The Consumer Healthcare Products Association has submitted comments to the citizen petition in opposition to the proposed repeal of regulation that allows for the use of titanium dioxide in food.

Industry concerns mount as FDA moves forward with plans to reorganize the agency, including the Office of Dietary Supplement Programs.

The seven claims bring the total self-substantiated claims submitted to FSANZ for Bimuno GOS to 29.

U.S. Senators, Richard J. Durbin (D-IL) and Richard Blumenthal (D-CT) have sent a letter to FDA commissioner Robert M. Califf, MD to address their concerns about the proposed reorganization of FDA’s Human Foods Program and Office of Regulatory Affairs.

The U.S. Food and Drug Administration has appointed James “Jim” Jones as the first Deputy Commissioner for Human Foods. Jones will be in charge of setting and advancing priorities for a proposed unified Human Foods Program (HFP).

The request seeks input on a range of factors, specifically: current market dynamics, pathways, scope, safety, quality, as well as form, packaging, accessibility and labeling. The deadline for submitting input was August 18, 2023.

The company's lacto-N-fucopentaose I with 2′-fucosyllactose, as well as hypoallergenic grade 2′-fucosyllactose and lacto-N-neotetraose are now GRAS.

Aker BioMarine has announced that its brain health ingredient, Lysoveta, has received an acknowledgement letter from the U.S. Food and Drug Administration (FDA) following its new dietary ingredient notification (NDIN).

The Council for Responsible Nutrition has sent a letter to Cara Welch, PhD, director of the Office of Dietary Supplement Programs, urging the ODSP to allocate the necessary resources to effectively enforce the dietary supplement master file framework.

NSF/ANSI 455-3 was developed to promote good manufacturing practices for cosmetics.

NPA explains in its petition that clarity is needed regarding the nomenclature and declaratory guidelines of dietary supplements derived from multicellular fungal species given the increasing public interest in mushroom products and ingredients.

Called Apex Compliance, the software detects risky marketing terms and phrases and suggests lower-risk alternatives.

The water-soluble powder ingredient will now be available across Europe for use in food supplements.

The company’s goal is to sell cultivated beef steaks under its Aleph Cuts brand in Switzerland.

The company has submitted Nutrition Fortifier (NF) dossiers for its GlyCare 3’-SL and 6’-SL ingredients to the China National Center for Food Safety Risk Assessment (CFSA) and National Health Committee (NHC).

Why is delta-8 THC such a hot-button topic?

“The Hemp Access and Consumer Safety Act” was previously proposed in 2021.

The July 27th hearing was called by the House Oversight and Accountability Committee’s Subcommittee on Health Care and Financial Services.

On July 17, FDA declined a request by U.S. Representative Jeff Duncan (R–SC) to hold a public hearing to clarify the agency’s recent stance that nicotinamide mononucleotide (NMN) is not allowed in dietary supplements.

Major supplement industry associations support the new bipartisan Dietary Supplements Access Act.

Here’s what brands need to know about the FDA’s Modernization of Cosmetics Regulation Act.

The Thailand Food and Drug Administration (TFDA) approved the algae-derived beta-glucan ingredient in food supplements for humans at a 375-mg daily dose.

Blood sugar–management supplements are capitalizing on growing consumer demand.

USDA’s Strengthening Organic Enforcement rule was finalized earlier this year. Here’s what companies need to know.

The Brazilian Health Regulatory Agency (ANVISA) approved Probiokid for use in infants and children aged 3 months to 36 months.

According to the letter, the position presented by Nammex “obfuscates the use well-established mycological definitions.”